ITUS CORPORATION (NASDAQ:ITUS) Files An 8-K Other Events
Item 8.01      Other Events

                  ITUS Corporation issued a press release announcing CchekÔ preliminary cancer patient efficacy study results. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

 (d) Exhibits

The following exhibits are filed with this Current Report on Form 8-K:

Exhibit No.         Description

 99.1                  Press Release dated December 7, 2016

About ITUS CORPORATION (NASDAQ:ITUS)

ITUS Corporation, formerly CopyTele, Inc., is engaged in development, acquisition, licensing, and enforcement of patented technologies that are either owned or controlled by the Company or one of its wholly owned subsidiaries. As on December 29, 2014, the Company owns and controls eight patent portfolios, including Encrypted Cellular Communication, Internet Telephonic Gateway, J-Channel Window Frame Construction, Key Based Web Conferencing Encryption, Micro Electro Mechanical Systems Display, Nano Field Emission Display, VPN Multicast Communications and Enhanced Auction Technologies. The Company monetizes its patented technologies, and settles patent infringement lawsuits. The Company’s business model is Patent Monetization and Patent Assertion.

ITUS CORPORATION (NASDAQ:ITUS) Recent Trading Information

ITUS CORPORATION (NASDAQ:ITUS) closed its last trading session 00.00 at 5.40 with 26,419 shares trading hands.